Additionally, PGAP3 silencing alone has reversed the malignant phenotype of NCI‐N87 cells in vitro, implying that PGAP3, not just a cooperator with ERBB2, may also play an important role in the progression of GC. The gene discussed is ERBB2; the disease is gastric cancer.